Site-specific splice variation of the human P2X4 receptorGrowth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin5-hydroxytryptamine and the gastrointestinal tract: where next?Evidence for the involvement of central 5-HT7 receptors in the micturition reflex in anaesthetized female ratsEvidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the ratDifferential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in ratsThe Concise Guide to PHARMACOLOGY 2013/14: overview.Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents.Prolonged anti-emetic activity and 5-HT3-receptor antagonism by BRL 46470 in conscious ferrets.Ghrelin and motilin receptor agonists: time to introduce bias into drug design.Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats.Analysis of the ghrelin receptor-independent vascular actions of ulimorelin.Treatment of nausea and vomiting: gaps in our knowledge.The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.The relationship between gastric motility and nausea: gastric prokinetic agents as treatments.Translating 5-HT receptor pharmacology.Intrinsic nerve circuits of the gastrointestinal tract: identification of drug targets.Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction.The hungry stomach: physiology, disease, and drug development opportunities.Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol.Pinane thromboxane A2 analogues are non-selective prostanoid antagonists in rat and human stomach muscle.Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers.The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.Defensive and pathological functions of the gastrointestinal NK3 receptor.Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying.Endocannabinoids and the gastrointestinal tract: what are the key questions?Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders.Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases.Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotilityThe translational value of rodent gastrointestinal functions: a cautionary tale.The identification of and rationale for drugs which act at the motilin receptor.Motilin receptor neuropharmacology: revised understanding.Nausea and the quest for the perfect anti-emetic.Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.Caffeine induces gastric acid secretion via bitter taste signaling in gastric parietal cells.
P50
Q22010634-378CA975-F582-4A33-8455-4E7A5562123CQ24312852-1AC17215-6BAC-43AF-BF61-4EE181D98E9FQ28304140-DEC2FCB8-8A6D-4AF3-8921-14C4FE20A5F1Q28574788-A57FB39B-D939-4CD9-B356-5FD734FEB380Q28578395-D8E1974D-1252-4850-9C94-9931A82359BAQ28581247-94d612a7-4cba-a4a2-a4c7-9bd1caeb7926Q30486728-71FE9217-4717-4D3B-ADCF-435BA1FF63AAQ33764577-96C38A9F-11B0-46DD-AE1E-26F3A2FBE8F3Q33990295-9A59DA4B-D963-4070-9A98-459B23294923Q33993111-8632F8A3-897C-4033-9868-7E937CD87113Q34323779-BD835458-3905-4936-B345-82FBFE08377CQ34398651-EB9BB51E-D07B-4488-AF45-8C2E4609670BQ34409219-2D652008-9473-4B33-8D68-3B825087D02CQ34432783-9D7590E3-EDE9-4D74-B273-B8794AF28384Q34463185-5F7D8488-FD40-4B98-841E-3D4B8C0A293DQ34560699-F9AF65A8-DC83-4560-B887-0722A5D6A162Q34645793-5F1D7FB3-6EB3-482B-AD34-25855F3A8C39Q34653943-23df0938-4a32-c658-5602-75eb8488aba9Q35012378-C2F66C84-8489-4EA1-878C-795C86315DD8Q35026085-06C0A7FC-6143-4C9F-BF91-2F181ADC4DEFQ35026102-5bd8cf42-4a3a-aba8-fa5c-1ea4d11f5290Q35215647-D4E42BAF-B6F2-4BA7-96F4-1BA6AE356679Q36096981-C51FCA1A-5E09-4E0D-8197-BDB8B0409BD2Q36097490-E0B7A875-8B84-4051-B7FA-D1AF3AFE7F12Q36128345-1A2DA051-5E6A-4444-BC5B-D38AB7B06925Q36466782-4740E650-F1F6-45E9-A238-336030525415Q36562462-AAC87650-0AA4-4FF5-B55F-062DD7B24EB9Q36619744-B97DBAB7-0A5B-41F8-9622-829BC3B04866Q36735824-EFC52164-31E9-4B29-B046-BFF9AE9C23FEQ36903406-6C738491-B813-44C5-9E57-DB43A74F8581Q36927486-5491A74C-DBE8-41BD-9C8F-9AE778353A40Q37097853-DF5B3D6A-2E43-4AAA-AADE-F931AFA67024Q37110778-32C3735F-D4B4-4CB4-9ED6-F34B6CD84CB2Q37337891-4CBD84CD-BDC6-4EDB-B2C1-2B6D0149E5DFQ37870550-A2D5EAAC-AD8B-46ED-9726-DB83599732ADQ37872279-B6CBD537-4483-424B-8AD6-9183DEFC18A3Q38031727-AF8542BC-015C-485B-B394-44B8EDACA29CQ38155385-b7755d8d-4668-1c9b-a223-b3b00423895cQ38590705-7AEFF97D-A4C5-49B9-B587-D67D4CF749EAQ38684444-28D5E898-C298-4C48-89BB-9B6327EA17DB
P50
description
onderzoeker
@nl
pharmacologist
@en
name
Gareth Sanger
@ast
Gareth Sanger
@en
Gareth Sanger
@es
Gareth Sanger
@fr
Gareth Sanger
@nl
Gareth Sanger
@sl
type
label
Gareth Sanger
@ast
Gareth Sanger
@en
Gareth Sanger
@es
Gareth Sanger
@fr
Gareth Sanger
@nl
Gareth Sanger
@sl
altLabel
Gareth J. Sanger
@en
prefLabel
Gareth Sanger
@ast
Gareth Sanger
@en
Gareth Sanger
@es
Gareth Sanger
@fr
Gareth Sanger
@nl
Gareth Sanger
@sl
P1015
P214
P244
P1015
P1153
7006049649
P21
P214
P244
P2798
P31
P3885
gareth-sanger
P496
0000-0002-4231-1945
P569
1953-01-01T00:00:00Z
2000-01-01T00:00:00Z
P6634
gareth-sanger-21a31810
P735
P7859
lccn-n92805664